Adeno-cre Virus Injection
Adeno-cre Virus Injection - Related Videos
08:47
Intracranial Injection of Adeno-associated Viral Vectors
0 Views •
Cited by 51 •
2010
Here we present the intracranial injection of AAV vectors for fluorescent labeling of neurons and glia in the visual cortex.
05:19
Segmental Adeno-Cre Infection: A Technique to Generate Isolated Colorectal Cancer using Genetically Engineered Mouse Models
0 Views •
2023
This video describes the generation of a colorectal mouse model by segmental adeno-cre infection. The infected colon segment leads to tumorigenesis within this segment of the mucosa, resulting in adenomas ultimately progressing to invasive and metastatic carcinoma. This model is an attractive platform for studies of cancer biology and preclinical therapeutic trials.
02:06
Harvesting Adeno-Associated Virus from Transfected Mammalian Cells
0 Views •
2026
Source: Rghei, A. D., et al. Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models. J. Vis. Exp. (2021)This video demonstrates the recovery of crude adeno-associated virus from transfected mammalian cells using chemical lysis and centrifugation, enabling high-yield AAV production for downstream purification and preclinical gene therapy applications.
02:08
Transduction of a Humanized Rat Liver Using Adeno-associated Virus Vectors
0 Views •
2026
Source: Hiller, T., et al. Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2. J. Vis. Exp., (2016)This video demonstrates adeno-associated virus-mediated gene delivery in a humanized rat liver scaffold. The vector delivers a transgene encoding a fluorescent reporter and gene-silencing RNA into liver cells via receptor-mediated endocytosis. This model supports efficient transduction in a perfused 3D liver tissue system.
02:44
Generation of Recombinant Adeno-Associated Virus Through Plasmid Transfection
0 Views •
2026
Source: Ding, J., et al. Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts. J. Vis. Exp. (2016)This video demonstrates the production of recombinant adeno-associated virus particles through plasmid transfection in mammalian cells. It highlights the coordinated expression of Rep, Cap, and helper proteins that drive viral genome replication and capsid assembly within the nucleus.
FAQs
The genetic outcome depends on how loxP sites are arranged around the target sequence. Cre recombinase recognizes these sites and can excise the DNA between them or invert it, changing gene activity in infected cells. This mechanism allows the same delivery strategy to produce different conditional genetic changes, depending on the engineered configuration of the experimental model.
LoxP placement determines whether Cre-mediated recombination removes a DNA segment or reverses its orientation. Consequently, the arrangement controls whether a conditional allele is activated, disrupted, or otherwise altered when Cre reaches the cell. Designing the loxP-flanked target appropriately is therefore essential for linking viral delivery to the intended change in gene activity.
Adeno-Cre virus injection provides Cre through adenoviral delivery that is generally transient rather than permanently expressed throughout the organism. This distinction limits the duration and distribution of recombinase activity, supporting experiments focused on selected tissues. It also helps investigators examine conditional genetic changes without establishing continuous Cre expression across all tissues.
The experimental model must contain a DNA sequence flanked by loxP sites so that delivered Cre can recognize and modify it. Without this conditional arrangement, Cre cannot produce the intended excision or inversion of the target sequence. Researchers therefore pair the viral delivery with a model designed to connect recombination in selected cells to a specific gene-activity change.
In cancer research, investigators use the approach to create conditional genetic changes in selected tissues by activating oncogenes or deleting tumor-suppressor genes. Restricting these changes spatially and temporally helps model events associated with tumor initiation and progression. The resulting system connects a defined genetic alteration with cancer development in the tissue where recombination occurs.
The method can help test how specific oncogene activation or tumor-suppressor loss contributes to tumor initiation and progression. Because Cre delivery can be directed to selected tissues and is generally transient, researchers can examine localized, conditional genetic events rather than relying only on changes expressed throughout the organism. This supports more controlled studies of cancer genetics.